GlobalDeal

Anokion

Biotechnology · Cambridge, United States

anokion.com

About Anokion

Anokion is a biotechnology company focused on developing innovative therapies for autoimmune diseases. The company leverages its proprietary technology platform to create targeted treatments that aim to restore immune tolerance and prevent the onset of autoimmune conditions. Anokion's approach is based on the understanding of the immune system's mechanisms and the role of specific antigens in disease progression. By utilizing a unique method of antigen delivery, Anokion seeks to provide safer and more effective treatment options for patients suffering from various autoimmune disorders. The company is committed to advancing its research and development efforts to bring new therapies to market that can significantly improve patient outcomes and quality of life. Anokion collaborates with leading research institutions and industry partners to enhance its scientific capabilities and accelerate the development of its product pipeline.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Therapeutics, Autoimmune Disease Treatment
Location
Cambridge, United States
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Anokion in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →